UL
Ulys LLC Portfolio holdings
AUM
$25.4M
This Quarter Return
-35.46%
1 Year Return
+201.03%
3 Year Return
-31.51%
5 Year Return
-50.88%
10 Year Return
–
AUM
$27.5M
AUM Growth
+$27.5M
(-34%)
Cap. Flow
+$424K
Cap. Flow
% of AUM
1.54%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Lexicon Pharmaceuticals
LXRX
|
$424K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Lexicon Pharmaceuticals
LXRX
$400M
| $27.5M | 99.97% | 30,248,505 +465,896 | +2% | +$424K |
|
|
CERE
2
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| $7K | 0.03% | 31,131 | – | – |
|